(Q43127278)
Statements
1 reference
Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors (English)
1 reference
Jan H M Schellens
1 reference
Marlies H G Langenberg
1 reference
Petronella O Witteveen
1 reference
Jeanine M Roodhart
1 reference
Henk M W Verheul
1 reference
Marja Mergui-Roelvink
1 reference
Jana van der Sar
1 reference
Erich Brendel
1 reference
Nicole Laferriere
1 reference
Emile E Voest
1 reference
16 March 2010
1 reference
1 reference
16
1 reference
7
1 reference
2187-2197
1 reference
Identifiers
1 reference
1 reference